These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23557042)

  • 21. The ethics of advertising strategies in the pharmaceutical industry.
    Reuter L
    Ethics Med; 2003; 19(3):171-5. PubMed ID: 14700051
    [No Abstract]   [Full Text] [Related]  

  • 22. Feeling Is Believing: Evaluative Conditioning and the Ethics of Pharmaceutical Advertising.
    Biegler P; Vargas P
    J Bioeth Inq; 2016 Jun; 13(2):271-9. PubMed ID: 26818244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The politics and strategy of industry self-regulation: the pharmaceutical industry's principles for ethical direct-to-consumer advertising as a deceptive blocking strategy.
    Arnold DG; Oakley JL
    J Health Polit Policy Law; 2013 Jun; 38(3):505-44. PubMed ID: 23418365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Both sides of pharmaceutical promotion.
    Crigger NJ; Bennison LW
    Adv Nurse Pract; 2007 Jan; 15(1):61-2, 64-5, 74. PubMed ID: 19998677
    [No Abstract]   [Full Text] [Related]  

  • 25. If direct-to-consumer advertisements come to Europe: lessons from the USA.
    Metzl JM
    Lancet; 2007 Feb; 369(9562):704-6. PubMed ID: 17321319
    [No Abstract]   [Full Text] [Related]  

  • 26. Disease-branding and drug-mongering: could pharmaceutical industry promotional practices result in tort liability?
    Cetel JS
    Seton Hall Law Rev; 2012; 42(2):643-702. PubMed ID: 22708139
    [No Abstract]   [Full Text] [Related]  

  • 27. College activities and the ethics of advertising.
    Ryan C; Walter G; Robertson M
    Australas Psychiatry; 2010 Apr; 18(2):101-5. PubMed ID: 20307152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Caution for false advertising].
    Heinzl S
    Med Monatsschr Pharm; 2003 Feb; 26(2):37. PubMed ID: 12619521
    [No Abstract]   [Full Text] [Related]  

  • 29. Ethical issues arising from commercial sponsorship and from relationships with the pharmaceutical industry--report and recommendations of the Ethics Subcommittee of the International Headache Society.
    Steiner TJ
    Cephalalgia; 2008 Sep; 28 Suppl 3():1-25. PubMed ID: 18666973
    [No Abstract]   [Full Text] [Related]  

  • 30. Adverse drug event reporting.
    Vaughan W
    Health Aff (Millwood); 2012 Aug; 31(8):1911. PubMed ID: 22869674
    [No Abstract]   [Full Text] [Related]  

  • 31. Medicine and the pharmaceutical industry.
    Baxter P
    Dev Med Child Neurol; 2006 Aug; 48(8):627. PubMed ID: 16836771
    [No Abstract]   [Full Text] [Related]  

  • 32. Ethical code of the pharmaceutical industry in Slovakia. (Excerpts).
    Med Etika Bioet; 2004; 11(3-4):11-22. PubMed ID: 16294449
    [No Abstract]   [Full Text] [Related]  

  • 33. Consumers and healthcare.
    Raven G
    Br Dent J; 2003 Dec; 195(11):619-20. PubMed ID: 14718987
    [No Abstract]   [Full Text] [Related]  

  • 34. Four drug companies breach industry's code of practice.
    Hawkes N
    BMJ; 2010 Dec; 341():c7266. PubMed ID: 21163846
    [No Abstract]   [Full Text] [Related]  

  • 35. To ban or not to ban--that is the question: the constitutionality of a moratorium on consumer drug advertising.
    Schwartz MI
    Food Drug Law J; 2008; 63(1):1-33. PubMed ID: 18561453
    [No Abstract]   [Full Text] [Related]  

  • 36. Sales reps: footsoldiers in drug company wars.
    Prescrire Int; 2004 Jun; 13(71):116. PubMed ID: 15233155
    [No Abstract]   [Full Text] [Related]  

  • 37. Academic Emergency Medicine can print pharmaceutical advertising while not compromising its mission or its integrity.
    Gaddis GM; Olson JE; Wright DW
    Acad Emerg Med; 2009 Oct; 16(10):978-81. PubMed ID: 19799574
    [No Abstract]   [Full Text] [Related]  

  • 38. An insider's perspective: defense of the pharmaceutical industry's marketing practices.
    Johar K
    Albany Law Rev; 2012-2013; 76(1):299-334. PubMed ID: 23577377
    [No Abstract]   [Full Text] [Related]  

  • 39. Restoring confidence in the pharmaceutical industry.
    Bauchner H; Fontanarosa PB
    JAMA; 2013 Feb; 309(6):607-9. PubMed ID: 23403686
    [No Abstract]   [Full Text] [Related]  

  • 40. Breach of code on the promotion of medicines.
    Vet Rec; 2015 Jul; 177(4):85. PubMed ID: 26206961
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.